| Name: | Brexpiprazole Impurity 2 |
| Catalogue No. | VL3840004 |
| CAS No. | 2094559-58-5 |
| Molecular Formula | C₃₈H₄₀N₄O₄S |
| Molecular Weight | 648.81 |
| Status | In-stock |
| IUPAC Name | 7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one |
| Description | Brexpiprazole Impurity 2 ( CAS No: 2094559-58-5 ) or 7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one is associate impurity of Brexpiprazole. Brexpiprazole is an atypical antipsychotic. Brexpiprazole is employed to treat schizophrenia and as adjunctive therapy to antidepressant medications for the treatment of the major depressive disorder (MDD). |
| References | “Sci-Hub | Brexpiprazole and Cariprazine: Distinguishing Two New Atypical Antipsychotics from the Original Dopamine Stabilizer Aripiprazole | 10.1177/2045125316672136.” Hkvisa.net, 2016, sci-hub.hkvisa.net/10.1177/2045125316672136. |
![7-Bromobenzo[b]thiophene](/public/site/files/site_images/thumb_7bromobenzobthiophene49299.png)
![6-Bromobenzo[b]thiophene](/public/site/files/site_images/thumb_6bromobenzobthiophene46341.png)
